FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892321152> ?p ?o ?g. }

• W2892321152 abstract "Gallbladder cancer (GBC) is one of the refractory diseases. Multidisciplinary approach including immunotherapy for such cancers has received much attention in recent years. A 59-year-old man underwent an extended cholecystectomy for GBC (pathological stage II, T2 N0 M0, [per UICC 7th edition]) that was incidentally found during cholelithiasis surgery, and was then treated with adjuvant gemcitabine (GEM). Three months later, when a recurrence-suspected lesion was detected in segment 5 (S5) of his liver, we started adoptive immunotherapies with cytokine-activated killer (CAK) cell infusions, combined with chemotherapy. After a year of adjuvant immunochemotherapy, the S5 lesion disappeared on imaging, but lesions suspected metastatic recurrence again appeared in S7 and S8 at 4 years and 6 months post-surgery, for which GEM and cisplatin (CDDP) were administered as second-line chemotherapy. Immunochemotherapy produced stable disease (per RECIST) for 9 months, when tumor growth was detected; open microwave coagulo-necrotic therapy (MCN) was performed for these lesions. Three years after MCN, a solitary liver metastasis was detected in S4. MCN was conducted again, and peritoneal dissemination was found intraoperatively. A month after the second MCN, the patient’s carcinoembryonic antigen (CEA) level had increased. Therefore, GEM and tegafur-gimeracil-oteracil potassium (TS-1) were administered as third-line chemotherapy. We also switched the adoptive immunotherapy for tumor-associated antigen-pulsed dendritic cell-activated killer (DAK) cell immunotherapy. After nine courses of GEM and TS-1 administration, CEA had decreased to a normal level. At the time of reporting, 9 years and 6 months have passed since the initial surgery, and 18 months have passed since the peritoneal metastasis was detected. GEM and CDDP are currently administered as fourth-line chemotherapy because of re-increased CEA. Although an undeniable metastasis was found in his para-aortic lymph node, this patient visits our clinic regularly for immunotherapy. We here report a rare case of long-term survival of recurrent GBC well controlled by multidisciplinary therapy. Immunotherapy may be a promising modality among multidisciplinary methods for advanced cancer." @default.
• W2892321152 created "2018-09-27" @default.
• W2892321152 creator A5027724595 @default.
• W2892321152 creator A5037672842 @default.
• W2892321152 creator A5039376946 @default.
• W2892321152 creator A5050319787 @default.
• W2892321152 creator A5064002818 @default.
• W2892321152 creator A5072862484 @default.
• W2892321152 creator A5073210962 @default.
• W2892321152 creator A5077613670 @default.
• W2892321152 creator A5078418006 @default.
• W2892321152 creator A5082390492 @default.
• W2892321152 date "2018-09-15" @default.
• W2892321152 modified "2023-09-27" @default.
• W2892321152 title "Long-term survival of a patient with recurrent gallbladder carcinoma, treated with chemotherapy, immunotherapy, and surgery: a case report" @default.
• W2892321152 cites W1990738112 @default.
• W2892321152 cites W2002617655 @default.
• W2892321152 cites W2016399957 @default.
• W2892321152 cites W2020322537 @default.
• W2892321152 cites W2025769688 @default.
• W2892321152 cites W2026091709 @default.
• W2892321152 cites W2028622385 @default.
• W2892321152 cites W2059679895 @default.
• W2892321152 cites W2065134430 @default.
• W2892321152 cites W2081498029 @default.
• W2892321152 cites W2087569038 @default.
• W2892321152 cites W2097968583 @default.
• W2892321152 cites W2108583660 @default.
• W2892321152 cites W2111348064 @default.
• W2892321152 cites W2128429040 @default.
• W2892321152 cites W2131506499 @default.
• W2892321152 cites W2143574380 @default.
• W2892321152 cites W2144344428 @default.
• W2892321152 cites W2145948646 @default.
• W2892321152 cites W2148360952 @default.
• W2892321152 cites W2187132487 @default.
• W2892321152 cites W2195172068 @default.
• W2892321152 cites W2470723789 @default.
• W2892321152 cites W2535969070 @default.
• W2892321152 doi "https://doi.org/10.1186/s40792-018-0512-6" @default.
• W2892321152 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6139108" @default.
• W2892321152 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30219954" @default.
• W2892321152 hasPublicationYear "2018" @default.
• W2892321152 type Work @default.
• W2892321152 sameAs 2892321152 @default.
• W2892321152 citedByCount "5" @default.
• W2892321152 countsByYear W28923211522021 @default.
• W2892321152 countsByYear W28923211522022 @default.
• W2892321152 countsByYear W28923211522023 @default.
• W2892321152 crossrefType "journal-article" @default.
• W2892321152 hasAuthorship W2892321152A5027724595 @default.
• W2892321152 hasAuthorship W2892321152A5037672842 @default.
• W2892321152 hasAuthorship W2892321152A5039376946 @default.
• W2892321152 hasAuthorship W2892321152A5050319787 @default.
• W2892321152 hasAuthorship W2892321152A5064002818 @default.
• W2892321152 hasAuthorship W2892321152A5072862484 @default.
• W2892321152 hasAuthorship W2892321152A5073210962 @default.
• W2892321152 hasAuthorship W2892321152A5077613670 @default.
• W2892321152 hasAuthorship W2892321152A5078418006 @default.
• W2892321152 hasAuthorship W2892321152A5082390492 @default.
• W2892321152 hasBestOaLocation W28923211521 @default.
• W2892321152 hasConcept C121608353 @default.
• W2892321152 hasConcept C126322002 @default.
• W2892321152 hasConcept C141071460 @default.
• W2892321152 hasConcept C143998085 @default.
• W2892321152 hasConcept C2776694085 @default.
• W2892321152 hasConcept C2777299880 @default.
• W2892321152 hasConcept C2777387746 @default.
• W2892321152 hasConcept C2777701055 @default.
• W2892321152 hasConcept C2779013556 @default.
• W2892321152 hasConcept C2780258809 @default.
• W2892321152 hasConcept C71924100 @default.
• W2892321152 hasConcept C90924648 @default.
• W2892321152 hasConceptScore W2892321152C121608353 @default.
• W2892321152 hasConceptScore W2892321152C126322002 @default.
• W2892321152 hasConceptScore W2892321152C141071460 @default.
• W2892321152 hasConceptScore W2892321152C143998085 @default.
• W2892321152 hasConceptScore W2892321152C2776694085 @default.
• W2892321152 hasConceptScore W2892321152C2777299880 @default.
• W2892321152 hasConceptScore W2892321152C2777387746 @default.
• W2892321152 hasConceptScore W2892321152C2777701055 @default.
• W2892321152 hasConceptScore W2892321152C2779013556 @default.
• W2892321152 hasConceptScore W2892321152C2780258809 @default.
• W2892321152 hasConceptScore W2892321152C71924100 @default.
• W2892321152 hasConceptScore W2892321152C90924648 @default.
• W2892321152 hasIssue "1" @default.
• W2892321152 hasLocation W28923211521 @default.
• W2892321152 hasLocation W28923211522 @default.
• W2892321152 hasLocation W28923211523 @default.
• W2892321152 hasLocation W28923211524 @default.
• W2892321152 hasOpenAccess W2892321152 @default.
• W2892321152 hasPrimaryLocation W28923211521 @default.
• W2892321152 hasRelatedWork W1990619355 @default.
• W2892321152 hasRelatedWork W1994207653 @default.
• W2892321152 hasRelatedWork W2080820783 @default.
• W2892321152 hasRelatedWork W2100029565 @default.
• W2892321152 hasRelatedWork W2113566724 @default.
• W2892321152 hasRelatedWork W2315587357 @default.
• W2892321152 hasRelatedWork W3032349186 @default.
• W2892321152 hasRelatedWork W3165554856 @default.

• next